Skip to main content
Log in

Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipients

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

To explore whether glycated albumin (GA) or fasting plasma glucose (FPG), both routinely monitored during patients’ hospital stay, can be used to predict post-transplantation diabetes mellitus (PTDM).

Methods

All kidney transplantation recipients (KTRs) from January 2017 to December 2018 were followed-up for 1 year. PTDM was diagnosed from day 45 post-operation to 1 year. When the completeness was above 80%, FPG or GA data on the day was selected, analyzed, and presented as range parameters and standard deviation (SD) and compared between PTDM and non-PTDM groups in fluctuation and stable periods. The predictive cut-off values were determined via receiver operating characteristic (ROC) analysis. The PTDM combined predictive mode, formed by the independent risk factors derived from logistic regression analyses, was compared with each independent risk factor with the independent ROC curve test.

Results

Among 536 KTRs, 38 patients developed PTDM up to 1 year post-operatively. The family history diabetes mellitus (OR, 3.21; P = 0.035), the FPG SD in fluctuation period >2.09 mmol/L (OR, 3.06; P = 0.002), and the FPG maximum in stable period >5.08 mmol/L (OR, 6.85; P < 0.001) were the PTDM independent risk factors. The discrimination of the combined mode (area under the curve = 0.81, sensitivity = 73.68%, and specificity = 76.31%) was higher than each prediction (P < 0.05).

Conclusions

The FPG standard deviation during the fluctuation period, FPG maximum during the stable period, and family history diabetes mellitus predicted PTDM with good discrimination and potential routine clinical use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. T. Dienemann, N. Fujii, Y. Li, S. Govani, N. Kosaraju, R.D. Bloom, H.I. Feldman, Long-term patient survival and kidney allograft survival in post-transplant diabetes mellitus: a single-center retrospective study. Transpl. Int. 29, 1017–1028 (2016)

    Article  CAS  PubMed  Google Scholar 

  2. M. Hecking, M. Haidinger, D. Döller, J. Werzowa, A. Tura, J. Zhang, M.D. Säemann, Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J. Am. Soc. Nephrol. 23, 739–749 (2012)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. D.M. Zelle, E. Corpeleijn, J. Deinum, R.P. Stolk, R.O. Gans, G. Navis, S.J. Bakker, Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation. Diabetes Care. 36, 1926–1932 (2013)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. T. Jenssen, A. Hartmann, Post-transplant diabetes mellitus in patients with solid organ transplants. Nat. Rev. Endocrinol. 15, 172–188 (2019)

    Article  PubMed  Google Scholar 

  5. K. Tokodai, N. Amada, I. Haga, T. Takayama, A. Nakamura, The 5-time point oral glucose tolerance test as a predictor of new-onset diabetes after kidney transplantation. Diabetes Res. Clin. Pr. 103, 298–303 (2014)

    Article  CAS  Google Scholar 

  6. S. Kesiraju, P. Paritala, U.M.R. Ch, S. Sahariah, New onset of diabetes after transplantation—an overview of epidemiology, mechanism of development and diagnosis. Transpl. Immunol. 30, 52–58 (2014)

    Article  PubMed  Google Scholar 

  7. E. Dozio, V. Corradi, M. Proglio, E. Vianello, L. Menicanti, R. Rigolini, C. Ronco, Usefulness of glycated albumin as a biomarker for glucose control and prognostic factor in chronic kidney disease patients on dialysis (CKD-G5D). Diabetes Res. Clin. Pract. 140, 9–17 (2018)

    Article  CAS  PubMed  Google Scholar 

  8. I.A. Eide, T.A.S. Halden, A. Hartmann, A. Asberg, D.O. Dahle, A.V. Reisaeter, T. Jenssen, Mortality risk in post-transplantation diabetes mellitus based on glucose and HbA1c diagnostic criteria. Transpl. Int. 29, 568–578 (2016)

    Article  CAS  PubMed  Google Scholar 

  9. S. Takahashi, H. Uchino, T. Shimizu, A. Kanazawa, Y. Tamura, K. Sakai, Y. Tanaka, Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr. J. 54, 139–144 (2007)

    Article  CAS  PubMed  Google Scholar 

  10. A. Raghav, J. Ahmad, Glycated albumin in chronic kidney disease: pathophysiologic connections. Diabetes Metab. Syndr. 12, 463–468 (2018)

    Article  PubMed  Google Scholar 

  11. K. Neelofar, J. Ahmad, An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus. Glycoconj. J. 34, 575–584 (2017)

    Article  CAS  PubMed  Google Scholar 

  12. J.M. Lu, L.N. Ji, Y.F. Li, Q.M. Li, S.S. Lin, X.F. Lv, Y. Gao, Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: a multicenter, prospective study. J. Diabetes Complicat. 30, 1609–1613 (2016)

    Article  Google Scholar 

  13. S. Bhat, M.G. Jagadeeshaprasad, V. Venkatasubramani, M.J. Kulkarni, Abundance matters: role of albumin in diabetes, a proteomics perspective. Expert Rev. Proteom. 14, 677–689 (2017)

    Article  CAS  Google Scholar 

  14. N. Furusyo, T. Koga, M. Ai, S. Otokozawa, T. Kohzuma, H. Ikezaki, J. Hayashi, Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the kyushu and okinawa population study (KOPS). Diabetologia. 54, 3028–3036 (2011)

    Article  CAS  PubMed  Google Scholar 

  15. A. Sinangil, V. Celik, S. Barlas, Y. Koc, T. Basturk, T. Sakaci, T. Ecder, The incidence of new onset diabetes after transplantation and related factors: single center experience. Nefrologia. 37, 181–188 (2017)

    Article  PubMed  Google Scholar 

  16. J. Werzowa, G. Pacini, M. Hecking, C. Fidler, M. Haidinger, H. Brath, A. Tura, Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus. J. Diabetes Complic. 29, 1211–1216 (2015)

    Article  Google Scholar 

  17. H.Y. Jin, K. Lee, Y.J. Kim, T.S. Park, S. Lee, S.K. Park, H.C. Yu, The degree of hyperglycemia excursion in patients of kidney transplantation (KT) or liver transplantation (LT) assessed by continuous glucose monitoring (CGM): pilot study. J. Diabetes Res. 2019, 1–10 (2019)

    Google Scholar 

  18. J. Huang, The “Chinese mode” of organ donation and transplantation. HepatoBiliary Surg. Nutr. 6, 212–214 (2017)

    Article  PubMed  PubMed Central  Google Scholar 

  19. T.S. Joseph, Wu, M. Kagoli, J.J. Kaasboll, G.A. Bjune, Integrated disease surveillance and response (IDSR) in malawi: implementation gaps and challenges for timely alert. Plos One. 13, e0200858 (2018)

    Article  Google Scholar 

  20. A. Sharif, M. Hecking, A.P.J. De Vries, E. Porrini, M. Hornum, S. Rasoul-Rockenschaub, M.D. Säemann, Proceedings from an international consensus meeting on posttransplantation diabetes mellitus: recommendations and future directions. Am. J. Transpl. 14, 1992–2000 (2014)

    Article  CAS  Google Scholar 

  21. V. Shivaswamy, B. Boerner, J. Larsen, Post-transplant diabetes mellitus: causes, treatment, and impact on outcomes. Endocr. Rev. 37, 37–61 (2016)

    Article  CAS  PubMed  Google Scholar 

  22. M. Xia, H. Yang, X. Tong, H. Xie, F. Cui, W. Shuang, Risk factors for new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. J. Diabetes Investig. 12, 109–122 (2020)

    Article  PubMed  PubMed Central  Google Scholar 

  23. A. Sharif, S. Cohney, Post-transplantation diabetes-state of the art. Lancet Diabetes Endocrinol. 4, 337–349 (2016)

    Article  PubMed  Google Scholar 

  24. D.D. De Lucena, J.R. De Sá, J.O. Medina-Pestana, E.B. Rangel, Modifiable variables are major risk factors for posttransplant diabetes mellitus in a time-dependent manner in kidney transplant: an observational cohort study. J. Diabetes Res. 2020, 1–10 (2020)

    Article  Google Scholar 

  25. J. Xu, L. Xu, X. Wei, X. Li, M. Cai, Incidence and risk factors of posttransplantation dia betes mellitus in living donor kidney transplantation: a single-center retrospective study in China. Transpl. Proc. 50, 3381–3385 (2018)

    Article  CAS  Google Scholar 

  26. R. Cai, M. Wu, Y. Xing, Pretransplant metabolic syndrome and its components predict post-transplantation diabetes mellitus in Chinese patients receiving a first renal transplant. Ther. Clin. Risk Manag. 15, 497–503 (2019)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. N.D. Bayer, P.T. Cochetti, M.S.A. Kumar, V. Teal, Y. Huan, C. Doria, S.E. Rosas, Association of metabolic syndrome with development of new-onset diabetes after transplantation. Transplantation. 90, 861–866 (2010)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. T. Szili-Torok, W. Annema, J.L. Anderson, S.J. Bakker, U.J. Tietge, High density lipoprotein cholesterol efflux predicts incident new onset diabetes after transplantation (NODAT) in renal transplant recipients independent of high density lipoprotein cholesterol levels. Diabetes. 68, 1–32 (2019)

    Article  Google Scholar 

  29. X. Lai, L. Zhang, J. Fang, G. Li, L. Xu, J. Ma, Z. Chen, OGTT 2-hour serum C-peptide index as a predictor of post-transplant diabetes mellitus in kidney transplant recipients. Ann. Transl. Med. 7, 538–546 (2019)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. X. He, L. Ying, X. Ma, Y. Shen, H. Su, J. Peng, W. Jia, An additional measurement of glycated albumin can help prevent missed diagnosis of diabetes in Chinese population. Clin. Chim. Acta. 475, 188–192 (2017)

    Article  CAS  PubMed  Google Scholar 

  31. S. Sokooti, F. Klont, S.C. Tye, D. Kremer, R.M. Douwes, G. Hopfgartner, R.P.F. Dullaart, H.J.L. Heerspink, S.J.L. Bakker, Association of diuretic use with increased risk for long-term post-transplantation diabetes mellitus in kidney transplant recipients. Nephrol. Dial. Transpl. 37, 1375–1383 (2022)

    Article  CAS  Google Scholar 

  32. J.B. Bang, C.K. Oh, Y.S. Kim, S.H. Kim, H.C. Yu, C.D. Kim, M.K. Ju, B.J. So, S.H. Lee, S.Y. Han, C.W. Jung, J.K. Kim, S.H. Lee, J.Y. Jeon, Insulin secretion and insulin resistance trajectories over 1 year after kidney transplantation: a multicenter prospective cohort study. Endocrinol. Metab. 35, 820–829 (2020)

    Article  CAS  Google Scholar 

  33. F. Cheng, Q. Li, J.L. Wang, Z.D. Wang, F. Zeng, Y. Zhang, Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation. Saudi Pharm. J. 30, 1088–1094 (2022)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This study was supported by the National Nature Science Foundation of China (No. 81771485 and 81971290), the Key Research and Development Program of Shaanxi Province (No. 2020SF-136), the Program for New Scientific and Technological Star of Shaanxi Province (No. 2019KJXX-046), Young Talent Support Plan of Shaanxi Province, the Clinical Research Award of the First Affiliated Hospital of Xi’an Jiaotong University, China (No. XJTU1AF2021CRF-012).

Author information

Authors and Affiliations

Authors

Contributions

LW and WG: study design and drafting of the manuscript. JH, YL, KS, SG, WZ, SZ, and CD: data acquisition and analysis and study supervision. LW, YL, and WG: statistical analysis. WG: obtained funding support. All authors have approved the final version and agreed to publish the manuscript.

Corresponding author

Correspondence to Wei Gao.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, L., Huang, J., Li, Y. et al. Postoperative fasting plasma glucose and family history diabetes mellitus can predict post-transplantation diabetes mellitus in kidney transplant recipients. Endocrine 81, 58–66 (2023). https://doi.org/10.1007/s12020-023-03374-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-023-03374-y

Keywords

Navigation